Severe Eosinophilic Asthma - Global Market Updates

AstraZeneca Fasenra approved in China for treating severe eosinophilic asthma, featuring an image of lungs and the medication.

Health

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

John - August 20, 2024 0

AstraZeneca's Fasenra (benralizumab) has been approved by China's National Medical Products Association (NMPA) for the treatment of severe eosinophilic asthma in patients aged 12...

28th Conference of Central and State Statistical Organizations Begins with Focus on Data-Driven Decision...

John - August 13, 2024

PM Modi Pays Tribute to Former PM Atal Bihari Vajpayee on His Death Anniversary

John - August 16, 2024

PM Modi Expresses Grief Over the Passing of Former Minister Natwar Singh

John - August 12, 2024

Airtel Becomes First to Bring Connectivity to Phobrang, India’s Furthest Border Village

John - August 14, 2024

Tag: Severe Eosinophilic Asthma

China Approves AstraZeneca’s Fasenra for Severe Eosinophilic Asthma

EDITOR PICKS

28th Conference of Central and State Statistical Organizations Begins with Focus on Data-Driven Decision...

PM Modi Pays Tribute to Former PM Atal Bihari Vajpayee on His Death Anniversary

PM Modi Expresses Grief Over the Passing of Former Minister Natwar Singh

Airtel Becomes First to Bring Connectivity to Phobrang, India’s Furthest Border Village

EVEN MORE NEWS

Samsung Food+ Upgrades AI-Powered Features for Smarter, Healthier Cooking at IFA...

NVIDIA Launches AI-Driven NIM Agent Blueprint to Revolutionize Drug Discovery

Samsung Partners With Qualcomm to Enhance In-Vehicle Infotainment Systems

POPULAR CATEGORY